Table 2

Demographic and clinical characteristics of the study cohort

CharacteristicsMean(SD)/median
(IQR)/n (%) n=61
Age (years)*62.4±12.6
Men (n, %)51 (83.6)
Hypertension (n, %)37 (60.7)
Diabetes mellitus (n, %)15 (24.6)
Smokers/ex-smokers (n, %)28 (45.9)
Atrial fibrillation (n, %)15 (24.6)
Previous stroke (n, %)11 (18.0)
OTT (minutes)*203.5±54.1
NIHSS score on admission†9 (5–14)
SBP on admission (mm Hg)*150.6±22.8
DBP on admission (mm Hg)*89.3±16.9
NLR†2.4 (1.7–5.9)
BG level on admission(mmol/L)*7.0±2.3
Homocysteine (mmol/L)*14.4±6.9
END (n, %)20 (32.8)
Severe MCA stenosis (n, %)31 (50.8)
MCA occlusion (n, %)17 (27.9)
Severe ICA stenosis (n, %)4 (6.5)
ICA occlusion (n, %)9 (14.8)
DWI-ASPECT score†7 (5–8)
MHVs (n, %)35 (57.4)
 Subtle (n, %) 8 (13.1)
 Moderate (n, %)23 (37.7)
 Extensive (n, %)4 (6.6)
SVD burden†0 (0–1)
  • *Mean±SD.

  • †Median (IQR).

  • ASPECT, Alberta Stroke Programme Early CT ; BG, blood glucose; DBP, diastolic blood pressure; DWI, diffusion-weighted imaging; END, early neurological deterioration; ICA, internal carotid artery; MCA, middle cerebral artery; MHVs, multiple hypointense vessels; NIHSS, National Institutes of Health Stroke Scale; NLR, neutrophil to lymphocyte ratio; OTT, onset to treatment time; SBP, systolic blood pressure; SVD, small vessel disease.